BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation is a funding opportunity from BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, up to 571835, closing August 31, 2028.
Aug 31, 2028
(762d left)Overview
PROJECT SUMMARY Patients diagnosed with glioblastoma (GBM) have a median overall survival of less than two years even after receiving multimodal therapies. Multiple factors account for this treatment resistance including: 1) Inability of therapies to cross the blood-brain barrier to reach invading cells; 2) GBM’s…